. 2020 Feb 14;2020:2018464. doi: 10.1155/2020/2018464

Table 4.

Linear correlation analysis between the cardiac magnetic resonance parameters and clinical data.

		LVMi (g/m²)	IVST (mm)	LVFW (mm)	RVFW (mm)	LVEF (%)	RVEF (%)
GH (ng/ml)	r ²	0.000	0.000	0.001	0.001	0.007	0.002
GH (ng/ml)	p	0.098	0.928	0.800	0.853	0.508	0.731
GH nadir (ng/ml)	r ²	0.002	0.003	0.000	0.000	0.005	0.002
GH nadir (ng/ml)	p	0.760	0.700	0.886	0.874	0.602	0.736
IGF-1 (ng/ml)	r ²	0.001	0.001	0.023	0.001	0.001	0.041
IGF-1 (ng/ml)	p	0.841	0.796	0.244	0.798	0.856	0.116
Age (years)	r ²	0.031	0.159^a	0.005	0.015	0.040	0.016
Age (years)	p	0.171	0.002^∗	0.602	0.346	0.125	0.334
Body mass index (kg/m²)	r ²	0.123^a	0.087^a	0.111^a	0.010	0.053	0.106^b
Body mass index (kg/m²)	p	0.006^∗	0.021^∗	0.009^∗	0.433	0.076	0.011^∗
Disease duration (months)	r ²	0.046	0.108^a	0.012	0.004	0.028	0.058
Disease duration (months)	p	0.098	0.010^∗	0.400	0.645	0.201	0.062

GH, growth hormone; IGF-1, insulin-like growth factor 1; LVMi, left ventricular mass index; IVST, interventricular septum thickness; LVFW, left ventricular free wall; RVFW, right ventricular free wall; LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction; ECV, extracellular volume. ^∗This indicates that the linear correlation between the CMRi parameter and the clinical data is significant (p < 0.05). ^a indicates a positive linear correlation. ^b indicates a negative linear correlation.